Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (BORAY) had Income after Taxes of 142.78M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
610.35M |
|
95.70M |
|
358.27M |
|
252.08M |
|
504.63M |
|
105.72M |
|
63.70M |
|
169.42M |
|
169.42M |
|
|
Income after Taxes |
142.78M |
142.78M |
|
97.78M |
|
142.78M |
|
105.72M |
|
140.60M |
|
623.78M |
|
678.68M |
|
0.15 |
|
0.15 |
|
| Balance Sheet Financials | |
620.74M |
|
334.91M |
|
814.59M |
|
1.44B |
|
427.60M |
|
378.66M |
|
446.87M |
|
874.47M |
|
560.86M |
|
360.41M |
|
560.86M |
|
634.94M |
|
| Cash Flow Statement Financials | |
144.57M |
|
-108.49M |
|
-44.20M |
|
187.12M |
|
162.97M |
|
-24.15M |
|
2.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.45 |
|
-- |
|
-- |
|
0.40 |
|
1.00 |
|
41.30% |
|
17.32% |
|
17.32% |
|
23.04% |
|
27.76% |
|
15.68% |
|
123.30M |
|
-- |
|
-- |
|
-- |
|
0.43 |
|
3.27 |
|
2.08 |
|
175.35 |
|
25.46% |
|
39.62% |
|
9.95% |
|
15.20% |
|
0.88 |
|
0.18 |
|
0.21 |
|